Abiopharma

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Waters - Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters - Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

ASML reports transactions under its current share buyback program